Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
ASH 2022: David Sallman, MD, Discusses Positive Phase I Dose Escalation Data for PRGN-3006 UltraCAR-T in AML Patients
ASH 2022: David Sallman, MD, Discusses Positive Phase I Dose Escalation Data for PRGN-3006 UltraCAR-T in AML Patients
Author
Oncology Times
Published
Tue 20 Dec 2022
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP30_121622.mp3
Share to:
